-
Innovation Ranking
NewInnovation Ranking – SPX Flow Inc
SPX Flow Inc (SPX Flow) , a subsidiary of Lone Star Fund is a provider of engineered solutions. The company carries out the engineering, designing, manufacturing and marketing of various products and solutions related to turnkey projects across various industries. Its portfolio of products consists of pumps, valves, mixers, filters, air dryers, hydraulic tools, homogenizers, separators, and heat exchangers. The company sells its products through a network of distributors in the US and other countries. It serves food and beverage,...
-
Sector Analysis
Peak Flow Meters Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Peak Flow Meters Market Report Overview The peak flow meters market size was valued at $24.8 million in 2023. Factors such as the growing awareness of the devices in early diagnosis and monitoring of chronic respiratory diseases will drive the growth of the market. Thus, the peak flow meters market will grow at a CAGR of more than 3% from 2023 to 2033. A Peak Flow Meter is used for the diagnosis and monitoring of diseases such as asthma, and...
-
Product Insights
NewLikelihood of Approval Analysis for Shock
Overview How likely is it that the drugs in Shock will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Shock Overview Shock is a medical condition characterized by a significant and life-threatening...
-
Product Insights
NewTotal Artificial Heart Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Total Artificial Heart Pipeline Market Report Overview A total artificial heart is a prosthetic device that is implanted into the body to replace the biological heart. The total artificial heart pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the...
-
Macroeconomic Analysis
NewAustralia PESTLE Insights – A Macroeconomic Outlook Report
Mining, manufacturing and utilities activities contributed 22.6% to the gross value added (GVA) in 2023, followed by financial intermediation, real estate and business activities (21.5%), wholesale, retail and hotels activities (9.8%). In nominal terms, the three sectors are expected to grow by 3.7% each in 2024. Four major metropolitan regions in Australia comprised 57.3% of the country’s population and accounted for 59.5% of the country’s GDP in 2023, according to GlobalData’s cities database.
-
Product Insights
NewLikelihood of Approval Analysis for Arteriosclerosis
Overview How likely is it that the drugs in Arteriosclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arteriosclerosis Overview Arteriosclerosis refers to the thickening and hardening of arteries due to...
-
New
Net Present Value Model: Acelyrin Inc’s Izokibep
Empower your strategies with our Net Present Value Model: Acelyrin Inc's Izokibep report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval Analysis for Peripheral Artery Occlusive Disease (PAOD)
Overview How likely is it that the drugs in Peripheral Artery Occlusive Disease (PAOD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Artery Occlusive Disease (PAOD) Overview Peripheral artery occlusive...
-
Product Insights
NewLikelihood of Approval Analysis for Stroke
Overview How likely is it that the drugs in Stroke will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stroke Overview A stroke, also known as a cerebrovascular accident (CVA), is a...
-
Company Insights
NewBlock – Competitor Profile
Block (formerly Square) is a US-based payment services provider that was launched in 2009. Effective from December 10, 2021, Square changed its legal name to Block. However, the company continues to offer its merchant services under the Square brand name, enabling businesses to accept payments through methods including debit and credit cards issued by all major scheme providers, as well as NFC-based solutions such as Google Pay and Apple Pay. For offline payments, the company offers an array of traditional...